MedTrace Logo

Comparison of Two Dosing Regimens of Intravenous Ketorolac for Post-Cesarean Pain Control

NCT07244757 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 126

Last updated 2026-01-13

No results posted yet for this study

Summary

we aim to compare the analgesic efficacy of two intravenous ketorolac dosing regimens as part of a multimodal analgesic protocol that includes local wound infiltration for postoperative pain management after elective cesarean delivery.

Conditions

  • Postoperative Analgesia
  • Cesarean Delivery
  • Ketorolac

Interventions

DRUG

Ketorolac 30 mg

administered intravenously as 30 mg diluted in 10 mL of normal saline and injected over more than 15 seconds

DRUG

Ketorolac 15mg

administered intravenously as either 15 mg diluted in 10 mL of normal saline and injected over more than 15 seconds.

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • ahmed hasanin · Cairo University Kasr Alainy Faculty of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-12-01
Primary Completion
2026-03-31
Completion
2026-03-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07244757 on ClinicalTrials.gov